HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NBC SECURITIES, INC. 1,378$520.01%
BANK OF MONTREAL /CAN/ 452,599$18,669,7090.01%
ONTARIO TEACHERS PENSION PLAN BOARD 14,464$552,5250.01%
Ballentine Partners, LLC 6,245$238,5590.01%
Neuberger Berman Group LLC 184,453$7,046,1040.01%
CAPITAL FUND MANAGEMENT S.A. 42,100$1,608,2200.01%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 254,001$9,702,8380.01%
Mariner, LLC 58,708$2,242,6460.01%
VIRGINIA RETIREMENT SYSTEMS ET AL 16,000$611,2000.01%
AMERIPRISE FINANCIAL INC 447,143$17,080,8560.01%
PEAPACK GLADSTONE FINANCIAL CORP 8,183$3130.01%
Fisher Asset Management, LLC 275,235$10,513,9770.01%
Mirae Asset Global Investments Co., Ltd. 75,798$2,895,4840.01%
ROYAL BANK OF CANADA 482,246$18,420,0000.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 26,867$1,026,3190.01%
BARCLAYS PLC 214,352$8,1870.01%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 101,211$3,8660.01%
Verition Fund Management LLC 10,327$394,4910.01%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 8,155$311,5210.01%
BANK OF AMERICA CORP /DE/ 1,190,236$45,467,0140.01%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.